Login / Signup

How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer.

Katalin BoérAmbrus KaposiJudit KocsisZsolt HorváthBalázs MadarasÁkos SávoltGyorgy Benjamin KlémentGabor Rubovszky
Published in: Cancers (2024)
The Oncotype DX test substantially improves decision accuracy in recommending adjuvant chemotherapy. It may be further improved with a consensus decision. In the case of pre-RS consensus against chemotherapy, the test can be spared.
Keyphrases
  • early stage
  • clinical practice
  • decision making
  • neuropathic pain
  • locally advanced
  • sentinel lymph node
  • lymph node
  • neoadjuvant chemotherapy